This increase in ROS is essential to drive the formation and progression of KRAS‐mutant cancer by upregulating survival and growth factor signaling (Weinberg et al, 2010) and generating mitochondrial DNA mutations (Ishikawa et al, 2008). This evidence concerns the gene KRAS and cancer.